BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31582735)

  • 1. P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway.
    Wang X; Xiu P; Wang F; Zhong J; Wei H; Xu Z; Liu F; Li J
    Oncol Rep; 2017 Aug; 38(2):755-766. PubMed ID: 28627623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
    Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C
    Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
    Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
    Cancer Lett; 2024 Jul; 595():217006. PubMed ID: 38823763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis.
    Yuan Y; Xu J; Jiang Q; Yang C; Wang N; Liu X; Piao HL; Lu S; Zhang X; Han L; Liu Z; Cai J; Liu F; Chen S; Liu J
    J Exp Clin Cancer Res; 2024 May; 43(1):133. PubMed ID: 38698462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of N- and O-linked Glycoproteins from 4T1 Murine Mammary Carcinoma Cells.
    Phang WM; Tan AA; Gopinath SC; Hashim OH; Kiew LV; Chen Y
    Int J Med Sci; 2016; 13(5):330-9. PubMed ID: 27226773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer.
    Mao Y; Zhu L; Huang Z; Luo C; Zhou T; Li L; Wang G; Yang Z; Qi W; Yang X; Gao G
    Endocr Relat Cancer; 2020 Jan; 27(1):23-39. PubMed ID: 31705798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-liver axis calibrates intestinal stem cell fitness.
    Kim G; Chen Z; Li J; Luo J; Castro-Martinez F; Wisniewski J; Cui K; Wang Y; Sun J; Ren X; Crawford SE; Becerra SP; Zhu J; Liu T; Wang S; Zhao K; Wu C
    Cell; 2024 Feb; 187(4):914-930.e20. PubMed ID: 38280375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERPINF1 Mediates Tumor Progression and Stemness in Glioma.
    Song L; Huo X; Li X; Xu X; Zheng Y; Li D; Zhang J; Wang K; Wang L; Wu Z
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Selected Serpins in Gastrointestinal (GI) Malignancies.
    Pączek S; Mroczko B
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pigment epithelium derived factor expression with cancer progression and prognosis: a meta-analysis study.
    Cheng G; Song C
    Discov Oncol; 2021 Dec; 12(1):61. PubMed ID: 35201465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells.
    Shi T; Iwama H; Fujita K; Kobara H; Nishiyama N; Fujihara S; Goda Y; Yoneyama H; Morishita A; Tani J; Yamada M; Nakahara M; Takuma K; Masaki T
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Translational Modifications of the Energy Guardian AMP-Activated Protein Kinase.
    Ovens AJ; Scott JW; Langendorf CG; Kemp BE; Oakhill JS; Smiles WJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect.
    Tian H; Zhu X; Lv Y; Jiao Y; Wang G
    Cancer Manag Res; 2020; 12():5957-5974. PubMed ID: 32765096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contrary intracellular and extracellular functions of PEDF in HCC development.
    Li C; Huang Z; Zhu L; Yu X; Gao T; Feng J; Hong H; Yin H; Zhou T; Qi W; Yang Z; Liu C; Yang X; Gao G
    Cell Death Dis; 2019 Oct; 10(10):742. PubMed ID: 31582735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas.
    Hou J; Ge C; Cui M; Liu T; Liu X; Tian H; Zhao F; Chen T; Cui Y; Yao M; Li J; Li H
    Cell Death Dis; 2017 Aug; 8(8):e2969. PubMed ID: 28771223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual regulation of adipose triglyceride lipase by pigment epithelium-derived factor: a novel mechanistic insight into progressive obesity.
    Dai Z; Qi W; Li C; Lu J; Mao Y; Yao Y; Li L; Zhang T; Hong H; Li S; Zhou T; Yang Z; Yang X; Gao G; Cai W
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):123-34. PubMed ID: 23850519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
    Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
    Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationships of PEDF.
    Kawaguchi T; Yamagishi SI; Sata M
    Curr Mol Med; 2010 Apr; 10(3):302-11. PubMed ID: 20236052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of PEDF in Pancreatic Cancer.
    Ansari D; Althini C; Ohlsson H; Bauden M; Andersson R
    Anticancer Res; 2019 Jul; 39(7):3311-3315. PubMed ID: 31262851
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.